• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 4, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2206-13
Classification Class III
Code Info 4010524355, 4010518464, 4010517947, 4010516062, 4010514826, 4010507392, 4010506029, 4010504818, 4010503337, 4010501851, 4010499271, 4010497910, 4010495665, 4010494055, 4010491689, 4010490120, 4010488628, 4010487504, 4010485973, 4010482183, 4010481281, 4010479330, 4010478451, 4010474047, 4010471633, 4010469507, 4010468806, 4010465637, 4010464407, 4010461473, 4010460645, 4010458117, 4010453450, 4010451579, 4010447611, 4010447306, 4010444375, 4010443536, 4010441073, 4010411298, 4010409700, 4010408327, 4010406301, 4010402687, 4010401931, 4010399283, 4010398658, 4010396016, and 4010395462.
Product Distributed Qty 49 units
Reason For Recall Blood products, collected from a donor, whose suitability to donate were not adequately determined, were distributed.

Event Detail

Event Id 55733
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma Inc
City Cleveland
State OH
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-03-15
Initial Firm Notification of Consignee or Public Other
Distribution Pattern IL.
-
-